Home Treatment of Pulmonary Embolism
|ClinicalTrials.gov Identifier: NCT00214929|
Recruitment Status : Unknown
Verified August 2005 by Carlos III Health Institute.
Recruitment status was: Active, not recruiting
First Posted : September 22, 2005
Last Update Posted : December 9, 2005
|Condition or disease||Intervention/treatment||Phase|
|Pulmonary Embolism||Behavioral: treatment at home||Phase 4|
In order to carry out the Cooperative Investigation Plan for home treatment of pulmonary embolism, a network of multidisciplinary groups was built with the participation of 10 groups, distributed in 6 different regions and integrated within the Spanish Society of Pneumology and Thoracic Surgery (SEPAR).
Those groups will share a database integrated in the Spanish Registry on Thromboembolic Disease (RIETE), which is a project already being carried out and in which many of the groups of the network already participate.
The research project will be a study developed in two phases. In the first phase, predictive profiles for a favourable progression of the disease in patients with pulmonary embolism will be studied using the actual management of the disease with the current assistance model.
In the second phase, a randomized study comparing the efficacy and safety of two models of home treatment ( discharge from hospital during the first 72 hours after the diagnosis of PE and discharge from hospital during the first 5 days) in patients previously selected, according to predefined criteria which were modified on the basis of the results of phase I versus the current assistance model will be developed
The results will be measured in terms of efficacy, safety, economic burden, and quality of life in both models (at home and at hospital).
|Study Type :||Interventional (Clinical Trial)|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Cooperative Investigation Plan for Home Treatment of Pulmonary Embolism|
|Study Start Date :||December 2004|
|Estimated Study Completion Date :||August 2005|
- -Thromboembolic recurrences
- -Bleeding Complications
- -Quality of life
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00214929
|Pneumology Service of HVR|
|Seville, Spain, 41013|
|Study Chair:||Remedios Otero, MD||Pneumology Service of Virgen de Rocio Hospital (Spain)|
|Principal Investigator:||Fernando Uresandi, MD||Pneumology Service.Cruces Hospital (Spain)|
|Principal Investigator:||David Jimenez, MD||Pneumology Service. Ramon y Cajal Hospital (Spain)|
|Principal Investigator:||Miguel A. Cabezudo, MD||Pneumology Service. H. Asturias (Spain)|
|Principal Investigator:||Francisco Conget, MD||Pneumology Service. Clinic Hospital of Zaragoza (Spain)|
|Principal Investigator:||Dolores Nauffal, MD||Pneumology Service. La Fe Hospital (Spain)|
|Principal Investigator:||Mikel Oribe, MD||Pneumology Service. Galdakao Hospital (Spain)|
|Principal Investigator:||Jose L. Lobo, MD||Pneumology Service. Txagorritxu Hospital (Spain)|
|Principal Investigator:||Fulgencio Gonzalez, MD||Pneumology Service. 12 de Octubre Hospital (Spain)|
|Principal Investigator:||Elena Laserna, MD||Pneumology Service. S.Juan de Dios Hospital (Spain)|